Type 1 Diabetes clinical trials
Showing 101–150 of 210 active trials. Describe your situation to see which ones you may be eligible for.
- Accuracy of Continuous Glucose Monitors During the Perioperative Period in Youth With Type 1 Diabetes
- Registry for Stage 2 Type 1 Diabetes
- Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes
- PRenatal and Obstetric Maternal Exposures and ISlet Autoantibodies in Early Life
- Immune Function and the Progression to T1D
- Breaking Disparities in Access to Advanced Diabetes Technologies in Children With Type 1 Diabetes
- Pancreas Ultrasound Imaging in type1 Diabetes
- Multivariable Artificial Pancreas: Detecting and Mitigating Unannounced Physical Activity and Acute Psychological Stress
- The T1D Exchange Registry
- General Population Level Estimation for Type 1 Diabetes Risk in Children During Routine Care Delivery
- Genetics Of Autoimmunity In Type I Diabetes
- Type 1 Diabetes Extension Study
- Long Term Surveillance of Islet Transplant Recipients Following Complete Graft Loss
- Long Term Follow up of Recipients of Functional Islet Allografts
- TrialNet Pathway to Prevention of T1D
- Circulating Biomarkers in the Development of Type 1 Diabetes
- Kidney Precision Medicine Project
- EXtremely Early-onset Type 1 Diabetes EXtremely Early-onset Type 1 Diabetes (A Musketeers' Memorandum Study)
- NYSCF Scientific Discovery Biobank
- GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
- Impact of Obesity on Microvascular Insulin Action and Cardiorespiratory Fitness in Type 1 Diabetes
- Health Behavior Intervention for Adults With Type 1 Diabetes
- SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
- Lipoprotein Kinetics in T1D
- Type 1 Diabetes and Obstructive Sleep Apnea
- Effect of Fasting on Hypoglycemic Counterregulation in Type 1 Diabetes
- Diabetes Learning in Virtual Environments Just in Time for Community Reentry
- T1CARE: A Trial of a Novel Intervention to Address Social Determinants of Health in Young Adults With Type 1 Diabetes
- The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People With Type 1 and Type 2 Diabetes
- Discovery Diabetes
- GLP-1Ra Impact on Metabolic Outcomes in Stage 2 T1DM While Receiving Teplizumab
- Food Insecurity Reduction & Strategy Team
- Starting Technology in At Risk Type 1 Diabetes Study
- The Effects of Fluoxetine and/or DHEA
- REAL-Fam Feasibility Study for Youth Diabetes Management
- Thrive With Type 1 Diabetes 2026
- Effects of Ketosis on Brain Function in Patients With T1DM
- Very Low Carbohydrate Diets and Glucagon Response in T1DM
- Diabetes Multimorbidity Typology, Trajectory, and Feasibility of an Audio Diary Mobile Application to Support Self-management
- Best Practice Advisories to Reduce Inequities in Technology Use for People With Type 1 Diabetes
- Cholesterol Lowering and Residual Risk in Diabetes, Type 1
- Effect of C-peptide on Hypoglycemic Counterregulation
- Obesity Complicating Type 1 Diabetes: GLP-1 Analogue Anti-obesity Treatment
- Utilizing Community Health Workers as Diabetes Technology Coaches for Children With Type 1 Diabetes Using Automated Insulin Delivery
- Type 1 Diabetes Management Using a Very Low Carbohydrate Versus Standard Diet
- Glu-COACH: a Peer-mentoring Intervention to Reduce Disparities in Continuous Glucose Monitor (CGM) Use
- Digital Mindfulness for Young Adults With Type 1 Diabetes
- Building and Sustaining Exercise Habits for Adults With Type 1 Diabetes
- Continuous Glucose Monitoring for Outpatient Diabetes Management After Hospital Discharge
- Implementing Food Referrals for Equity and Sustained Health
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.